| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pleural Neoplasms | 4 | 2019 | 71 | 1.70 | Why? |
| Mesothelioma | 4 | 2019 | 76 | 1.66 | Why? |
| Thymus Neoplasms | 3 | 2019 | 69 | 1.64 | Why? |
| Thymectomy | 2 | 2019 | 26 | 1.54 | Why? |
| Lung Transplantation | 7 | 2020 | 1554 | 1.52 | Why? |
| Thymoma | 2 | 2019 | 47 | 1.47 | Why? |
| Pneumonectomy | 4 | 2019 | 278 | 1.28 | Why? |
| Lung Neoplasms | 9 | 2020 | 3228 | 1.27 | Why? |
| Antihypertensive Agents | 6 | 2020 | 1962 | 1.06 | Why? |
| Myasthenia Gravis | 2 | 2019 | 385 | 0.99 | Why? |
| Induction Chemotherapy | 2 | 2019 | 149 | 0.87 | Why? |
| Medication Adherence | 3 | 2020 | 1270 | 0.87 | Why? |
| Thyroid Nuclear Factor 1 | 1 | 2019 | 12 | 0.81 | Why? |
| Vascular Ring | 1 | 2018 | 3 | 0.79 | Why? |
| Health Services Administration | 1 | 2019 | 42 | 0.79 | Why? |
| Tracheoesophageal Fistula | 1 | 2018 | 32 | 0.75 | Why? |
| Thoracotomy | 1 | 2018 | 85 | 0.74 | Why? |
| Sternotomy | 1 | 2018 | 45 | 0.74 | Why? |
| Anastomosis, Surgical | 1 | 2019 | 169 | 0.73 | Why? |
| Aorta, Thoracic | 2 | 2018 | 271 | 0.73 | Why? |
| Thymus Gland | 1 | 2018 | 126 | 0.69 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 1510 | 0.69 | Why? |
| Tissue Donors | 2 | 2017 | 1679 | 0.69 | Why? |
| Perfusion | 1 | 2017 | 254 | 0.62 | Why? |
| Pleura | 1 | 2017 | 178 | 0.60 | Why? |
| Tissue and Organ Harvesting | 1 | 2017 | 146 | 0.60 | Why? |
| Thoracic Surgical Procedures | 2 | 2020 | 504 | 0.58 | Why? |
| Drug Therapy, Combination | 3 | 2018 | 7268 | 0.57 | Why? |
| Medication Therapy Management | 1 | 2018 | 312 | 0.57 | Why? |
| Robotic Surgical Procedures | 2 | 2019 | 787 | 0.52 | Why? |
| Hypertension | 3 | 2020 | 8895 | 0.50 | Why? |
| Neoplasms, Second Primary | 1 | 2013 | 100 | 0.49 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 595 | 0.48 | Why? |
| Myocardial Ischemia | 1 | 2019 | 781 | 0.48 | Why? |
| Bronchi | 1 | 2019 | 1048 | 0.47 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.43 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 896 | 0.40 | Why? |
| Chylothorax | 1 | 2008 | 5 | 0.38 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.38 | Why? |
| Waiting Lists | 1 | 2017 | 1388 | 0.38 | Why? |
| Cardiovascular Diseases | 7 | 2020 | 11497 | 0.38 | Why? |
| Pleurodesis | 1 | 2008 | 18 | 0.37 | Why? |
| Povidone | 1 | 2008 | 21 | 0.37 | Why? |
| Databases, Factual | 5 | 2019 | 6248 | 0.37 | Why? |
| Lymphangioleiomyomatosis | 1 | 2008 | 39 | 0.35 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.35 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 3832 | 0.33 | Why? |
| Myocardial Infarction | 2 | 2019 | 3361 | 0.30 | Why? |
| Italy | 19 | 2021 | 38444 | 0.28 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.28 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.26 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.25 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.24 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.23 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.23 | Why? |
| Aged | 29 | 2021 | 215776 | 0.22 | Why? |
| Male | 38 | 2021 | 367725 | 0.22 | Why? |
| Muscles | 1 | 2021 | 152 | 0.21 | Why? |
| Postoperative Period | 2 | 2020 | 651 | 0.21 | Why? |
| Vascular System Injuries | 1 | 2021 | 91 | 0.21 | Why? |
| Health Care Costs | 2 | 2019 | 1007 | 0.20 | Why? |
| Female | 38 | 2021 | 380317 | 0.20 | Why? |
| Hyperkalemia | 1 | 2021 | 140 | 0.20 | Why? |
| Arthralgia | 1 | 2021 | 173 | 0.19 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.19 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.19 | Why? |
| Sternum | 1 | 2018 | 30 | 0.19 | Why? |
| Pregnancy in Diabetics | 1 | 2019 | 56 | 0.19 | Why? |
| Neoplasms, Glandular and Epithelial | 1 | 2018 | 39 | 0.19 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.19 | Why? |
| Creatine Kinase | 1 | 2021 | 386 | 0.19 | Why? |
| Stroke | 2 | 2019 | 8839 | 0.18 | Why? |
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 97 | 0.18 | Why? |
| Primary Graft Dysfunction | 1 | 2018 | 44 | 0.18 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2017 | 29 | 0.18 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.18 | Why? |
| Urinary Tract | 1 | 2018 | 77 | 0.18 | Why? |
| Drug Utilization Review | 1 | 2018 | 72 | 0.18 | Why? |
| Organ Preservation | 1 | 2018 | 49 | 0.18 | Why? |
| Humans | 50 | 2021 | 930598 | 0.17 | Why? |
| Cardiovascular Abnormalities | 1 | 2018 | 72 | 0.17 | Why? |
| Abnormalities, Drug-Induced | 1 | 2018 | 72 | 0.17 | Why? |
| Chemotherapy, Adjuvant | 2 | 2018 | 606 | 0.17 | Why? |
| Radiotherapy, Adjuvant | 1 | 2017 | 180 | 0.16 | Why? |
| Maternal Exposure | 1 | 2018 | 173 | 0.16 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.15 | Why? |
| Heart Failure | 4 | 2018 | 6638 | 0.15 | Why? |
| Thoracic Surgery | 2 | 2020 | 623 | 0.15 | Why? |
| Drug Utilization | 2 | 2018 | 619 | 0.15 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.14 | Why? |
| Myalgia | 1 | 2021 | 1015 | 0.14 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2018 | 450 | 0.14 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2017 | 418 | 0.14 | Why? |
| Thyroid Gland | 1 | 2019 | 516 | 0.13 | Why? |
| Cohort Studies | 9 | 2021 | 36005 | 0.13 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.13 | Why? |
| Comorbidity | 6 | 2021 | 34796 | 0.13 | Why? |
| Risk Adjustment | 1 | 2017 | 730 | 0.13 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.13 | Why? |
| Outpatient Clinics, Hospital | 1 | 2018 | 523 | 0.13 | Why? |
| Antidepressive Agents | 1 | 2018 | 509 | 0.12 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.12 | Why? |
| Survival Rate | 2 | 2017 | 9206 | 0.12 | Why? |
| Ischemic Attack, Transient | 1 | 2017 | 439 | 0.12 | Why? |
| Area Under Curve | 1 | 2019 | 2564 | 0.12 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.11 | Why? |
| Pulmonary Alveoli | 1 | 2017 | 867 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 1454 | 0.11 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2019 | 1458 | 0.11 | Why? |
| Hospital Mortality | 4 | 2019 | 22087 | 0.11 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.11 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.11 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.10 | Why? |
| Tomography, X-Ray Computed | 5 | 2021 | 25144 | 0.10 | Why? |
| Cystic Fibrosis | 1 | 2020 | 1104 | 0.10 | Why? |
| Musculoskeletal Diseases | 1 | 2018 | 646 | 0.10 | Why? |
| National Health Programs | 1 | 2017 | 807 | 0.10 | Why? |
| Antipsychotic Agents | 1 | 2019 | 887 | 0.10 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.10 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.10 | Why? |
| Proportional Hazards Models | 2 | 2019 | 6543 | 0.10 | Why? |
| Patient Compliance | 1 | 2019 | 1468 | 0.10 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 5002 | 0.09 | Why? |
| Lung | 2 | 2018 | 31049 | 0.09 | Why? |
| Adult | 13 | 2021 | 244371 | 0.09 | Why? |
| Preoperative Care | 1 | 2019 | 1515 | 0.09 | Why? |
| Survival Analysis | 2 | 2019 | 7592 | 0.09 | Why? |
| State Medicine | 2 | 2019 | 2847 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2021 | 3755 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Residence Characteristics | 1 | 2018 | 1927 | 0.09 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2019 | 6166 | 0.08 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.08 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Case-Control Studies | 4 | 2020 | 17671 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2019 | 1969 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2017 | 2510 | 0.07 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.06 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.06 | Why? |
| Drug Interactions | 2 | 2019 | 1653 | 0.05 | Why? |
| Risk Assessment | 3 | 2019 | 25439 | 0.05 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.05 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.05 | Why? |
| Tibial Fractures | 1 | 2019 | 32 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| Organ Preservation Solutions | 1 | 2018 | 20 | 0.05 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Anthropology, Medical | 1 | 2017 | 50 | 0.04 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Pregnancy Trimester, First | 1 | 2018 | 366 | 0.04 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.04 | Why? |
| Accidental Falls | 1 | 2019 | 448 | 0.04 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Cryopreservation | 1 | 2018 | 464 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.03 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Patient Participation | 1 | 2017 | 829 | 0.03 | Why? |
| Health Services for the Aged | 1 | 2017 | 602 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2019 | 2165 | 0.02 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.02 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Surgeons | 1 | 2018 | 2233 | 0.02 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2019 | 5486 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.01 | Why? |